FDA to Meet Drug Approval Goals Despite Cuts, Commissioner Says

The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the agency’s commissioner said.

The FDA “will have no problem” approving new drugs on time, Marty Makary said at a Jefferies investor conference Wednesday. “That is the top priority at the agency.”